{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohorting&page=87", "query": { "intervention": "Cohorting", "page": 87 }, "page_size": 10 }, "pagination": { "page": 87, "page_size": 10, "total_count": 11377, "total_pages": 1138, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohorting&page=88&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohorting&page=86&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T09:46:09.811Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01430299", "title": "Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stenosis", "Spondylosis", "Degenerative Changes" ], "interventions": [ { "name": "Demineralized Bone Matrix", "type": "DEVICE" }, { "name": "rh-BMP2", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "SeaSpine, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2011-06", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2018-06-07", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01430299" }, { "nct_id": "NCT04441099", "title": "NBE-002 in Patients With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumor", "Advanced Cancer", "Triple Negative Breast Cancer" ], "interventions": [ { "name": "NBE-002", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NBE-Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2020-06-19", "completion_date": "2023-08-14", "has_results": false, "last_update_posted_date": "2023-09-07", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 3, "location_summary": "Nashville, Tennessee • Houston, Texas • San Antonio, Texas", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04441099" }, { "nct_id": "NCT02049398", "title": "Study of Variation Over Time in the Oral Microbiome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Microbiota", "Oral Health", "Body Mass Index" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2014-01-28", "completion_date": "2015-12-23", "has_results": false, "last_update_posted_date": "2020-11-27", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02049398" }, { "nct_id": "NCT05027971", "title": "Flexiva Pulse Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urinary Calculi", "Benign Prostatic Hyperplasia" ], "interventions": [ { "name": "Flexiva Pulse High Power Single-Use Laser Fibers", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 201, "start_date": "2021-11-01", "completion_date": "2023-10-31", "has_results": true, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 4, "location_summary": "Phoenix, Arizona • Miami, Florida • Orlando, Florida + 1 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Allentown", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05027971" }, { "nct_id": "NCT05292664", "title": "Venetoclax Basket Trial for High Risk Hematologic Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Myelodysplastic Syndromes, de Novo", "Myelodysplastic Syndromes, Secondary", "Myelodysplastic Syndromes, Previously Treated", "Treatment-Related Acute Myeloid Leukemia", "Therapy-Related Myelodysplastic Syndrome", "Acute Lymphoblastic Leukemia, in Relapse", "Acute Lymphoblastic Leukemia With Failed Remission", "Lymphoblastic Lymphoma, in Relapse", "Lymphoblastic Lymphoma, Refractory", "Acute Leukemia of Ambiguous Lineage in Relapse", "Acute Leukemia of Ambiguous Lineage" ], "interventions": [ { "name": "Venetoclax", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Dexrazoxane", "type": "DRUG" }, { "name": "Calaspargase Pegol", "type": "DRUG" }, { "name": "Erwinia asparaginase", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Andrew E. Place, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "40 Years", "sex": "ALL", "summary": "1 Year to 40 Years" }, "enrollment_count": 30, "start_date": "2023-03-29", "completion_date": "2030-07-02", "has_results": false, "last_update_posted_date": "2026-03-12", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 5, "location_summary": "San Francisco, California • Aurora, Colorado • Atlanta, Georgia + 2 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05292664" }, { "nct_id": "NCT04843904", "title": "Safe Accelerated Venetoclax Escalation in CLL", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma" ], "interventions": [ { "name": "Venetoclax", "type": "DRUG" }, { "name": "Obinutuzumab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2021-04-14", "completion_date": "2030-06-02", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04843904" }, { "nct_id": "NCT06669936", "title": "Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Recurrent C. Difficile Infection" ], "interventions": [ { "name": "Fecal microbiota transplantation ± bezlotoxumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexander Khoruts", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 24, "start_date": "2018-05-01", "completion_date": "2024-10-28", "has_results": false, "last_update_posted_date": "2024-11-01", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06669936" }, { "nct_id": "NCT05413421", "title": "Study of ORIC-944 in Patients With Metastatic Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Prostate Cancer" ], "interventions": [ { "name": "ORIC-944", "type": "DRUG" }, { "name": "Abiraterone acetate (Zytiga®) 250 mg or 500 mg tablets", "type": "DRUG" }, { "name": "Apalutamide (Erleada™) 60 mg or 240 mg tablets", "type": "DRUG" }, { "name": "Darolutamide (Nubeqa®) 300 mg tablets", "type": "DRUG" }, { "name": "Enzalutamide (Xtandi®) 40 mg capsules or 40 mg and 80 mg tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ORIC Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 275, "start_date": "2022-06-01", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 20, "location_summary": "Colorado Springs, Colorado • Plantation, Florida • Arlington Heights, Illinois + 17 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Plantation", "state": "Florida" }, { "city": "Arlington Heights", "state": "Illinois" }, { "city": "Lake Barrington", "state": "Illinois" }, { "city": "Jeffersonville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05413421" }, { "nct_id": "NCT07266363", "title": "Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ESCC" ], "interventions": [ { "name": "Small RNA sequencing of exo- and cf-miRNAs", "type": "DIAGNOSTIC_TEST" }, { "name": "RT-qPCR quantification of cf- and exo-miRNAs (SYNERGY assay)", "type": "DIAGNOSTIC_TEST" }, { "name": "PCR-based validation (SYNERGY assay)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2025-01-15", "completion_date": "2028-06-18", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 1, "location_summary": "Monrovia, California", "locations": [ { "city": "Monrovia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07266363" }, { "nct_id": "NCT00939263", "title": "Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Deglutition Disorders", "Esophageal Diseases", "Eosinophilia" ], "interventions": [ { "name": "assessment of disease activity using the EEsAI", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Insel Gruppe AG, University Hospital Bern", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 650, "start_date": "2011-01", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2015-09-16", "last_synced_at": "2026-11-02T09:46:09.811Z", "location_count": 14, "location_summary": "Scottsdale, Arizona • San Diego, California • Aurora, Colorado + 10 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00939263" } ] }